Factors affecting the place of death in patients with liver cancer in China, 2013–2020: A population-based study

Background: Despite the country's substantial liver cancer burden, there is limited research on the factors influencing the place of death (POD) of patients with liver cancer in China. This study aimed to delineate POD distribution among patients with liver cancer, identify the factors associat...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaosheng Ding, Weiwei Shi, Jinlei Qi, Juan An, Weiran Xu, Hui Shi, Xixi Zheng, Xiaoyan Li
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Cancer Pathogenesis and Therapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2949713224000259
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850035142333038592
author Xiaosheng Ding
Weiwei Shi
Jinlei Qi
Juan An
Weiran Xu
Hui Shi
Xixi Zheng
Xiaoyan Li
author_facet Xiaosheng Ding
Weiwei Shi
Jinlei Qi
Juan An
Weiran Xu
Hui Shi
Xixi Zheng
Xiaoyan Li
author_sort Xiaosheng Ding
collection DOAJ
description Background: Despite the country's substantial liver cancer burden, there is limited research on the factors influencing the place of death (POD) of patients with liver cancer in China. This study aimed to delineate POD distribution among patients with liver cancer, identify the factors associated with hospital deaths, and offer valuable insights for the government to develop healthcare policies. Methods: Data from 2013 to 2020 were obtained from the National Mortality Surveillance System (NMSS) of China. This analysis focused on the distribution of POD among individuals who succumbed to liver cancer. Variations in characteristic distributions across different categories were evaluated using a chi-squared test. We also applied a multilevel logistic regression analysis to identify the factors associated with hospital liver cancer deaths. The proportional change in variance was computed to evaluate the contributions of different factors in the model. Results: From 2013 to 2020, the NMSS reported a total of 608,789 liver cancer-related deaths, of which 440,079 (72.29%) died at home, and 158,291 (26.00%) died in the hospital. Home remained the preferred POD among patients with liver cancer. The results demonstrated that female patients, aged between 0 and 14 years, of Han ethnicity, living in urban areas, unmarried, highly educated, and either employed in a professional, staff, or civil servant capacity, or retired patients tended to end their lives in the hospital. Conclusions: In China, home continues to be the predominant POD for patients with liver cancer, with demographic and socioeconomic factors significantly influencing whether a hospital is their POD. Enhancing healthcare policymakers' understanding of the factors influencing the place of death for patients with liver cancer may assist in creating a more equitable distribution of healthcare resources and providing a variety of choices for minorities with distinct preferences for end-of-life care.
format Article
id doaj-art-46bae0ec0acb4faa962ba99e6120293b
institution DOAJ
issn 2949-7132
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series Cancer Pathogenesis and Therapy
spelling doaj-art-46bae0ec0acb4faa962ba99e6120293b2025-08-20T02:57:35ZengElsevierCancer Pathogenesis and Therapy2949-71322025-03-013216317210.1016/j.cpt.2024.04.001Factors affecting the place of death in patients with liver cancer in China, 2013–2020: A population-based studyXiaosheng Ding0Weiwei Shi1Jinlei Qi2Juan An3Weiran Xu4Hui Shi5Xixi Zheng6Xiaoyan Li7Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, ChinaDepartment of Oncology, PLA General Hospital, Beijing 100853, ChinaNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, ChinaDepartment of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, ChinaDepartment of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, ChinaDepartment of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, ChinaDepartment of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, ChinaDepartment of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China; Corresponding author: Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, No. 119 Nansihuan West Road Fengtai District, Beijing 100070, China.Background: Despite the country's substantial liver cancer burden, there is limited research on the factors influencing the place of death (POD) of patients with liver cancer in China. This study aimed to delineate POD distribution among patients with liver cancer, identify the factors associated with hospital deaths, and offer valuable insights for the government to develop healthcare policies. Methods: Data from 2013 to 2020 were obtained from the National Mortality Surveillance System (NMSS) of China. This analysis focused on the distribution of POD among individuals who succumbed to liver cancer. Variations in characteristic distributions across different categories were evaluated using a chi-squared test. We also applied a multilevel logistic regression analysis to identify the factors associated with hospital liver cancer deaths. The proportional change in variance was computed to evaluate the contributions of different factors in the model. Results: From 2013 to 2020, the NMSS reported a total of 608,789 liver cancer-related deaths, of which 440,079 (72.29%) died at home, and 158,291 (26.00%) died in the hospital. Home remained the preferred POD among patients with liver cancer. The results demonstrated that female patients, aged between 0 and 14 years, of Han ethnicity, living in urban areas, unmarried, highly educated, and either employed in a professional, staff, or civil servant capacity, or retired patients tended to end their lives in the hospital. Conclusions: In China, home continues to be the predominant POD for patients with liver cancer, with demographic and socioeconomic factors significantly influencing whether a hospital is their POD. Enhancing healthcare policymakers' understanding of the factors influencing the place of death for patients with liver cancer may assist in creating a more equitable distribution of healthcare resources and providing a variety of choices for minorities with distinct preferences for end-of-life care.http://www.sciencedirect.com/science/article/pii/S2949713224000259Liver neoplasmsPlace of deathSocioeconomic statusChina
spellingShingle Xiaosheng Ding
Weiwei Shi
Jinlei Qi
Juan An
Weiran Xu
Hui Shi
Xixi Zheng
Xiaoyan Li
Factors affecting the place of death in patients with liver cancer in China, 2013–2020: A population-based study
Cancer Pathogenesis and Therapy
Liver neoplasms
Place of death
Socioeconomic status
China
title Factors affecting the place of death in patients with liver cancer in China, 2013–2020: A population-based study
title_full Factors affecting the place of death in patients with liver cancer in China, 2013–2020: A population-based study
title_fullStr Factors affecting the place of death in patients with liver cancer in China, 2013–2020: A population-based study
title_full_unstemmed Factors affecting the place of death in patients with liver cancer in China, 2013–2020: A population-based study
title_short Factors affecting the place of death in patients with liver cancer in China, 2013–2020: A population-based study
title_sort factors affecting the place of death in patients with liver cancer in china 2013 2020 a population based study
topic Liver neoplasms
Place of death
Socioeconomic status
China
url http://www.sciencedirect.com/science/article/pii/S2949713224000259
work_keys_str_mv AT xiaoshengding factorsaffectingtheplaceofdeathinpatientswithlivercancerinchina20132020apopulationbasedstudy
AT weiweishi factorsaffectingtheplaceofdeathinpatientswithlivercancerinchina20132020apopulationbasedstudy
AT jinleiqi factorsaffectingtheplaceofdeathinpatientswithlivercancerinchina20132020apopulationbasedstudy
AT juanan factorsaffectingtheplaceofdeathinpatientswithlivercancerinchina20132020apopulationbasedstudy
AT weiranxu factorsaffectingtheplaceofdeathinpatientswithlivercancerinchina20132020apopulationbasedstudy
AT huishi factorsaffectingtheplaceofdeathinpatientswithlivercancerinchina20132020apopulationbasedstudy
AT xixizheng factorsaffectingtheplaceofdeathinpatientswithlivercancerinchina20132020apopulationbasedstudy
AT xiaoyanli factorsaffectingtheplaceofdeathinpatientswithlivercancerinchina20132020apopulationbasedstudy